drugset / Trial / NCT00481182

Co-Administration Of Fosamprenavir With Methadone: A Drug Interaction Study.

NCT00481182

Phase 1 Completed 20 enrolled GlaxoSmithKline
Non-randomizedSingle-groupOpen-labelTreatment

Summary

To assess the combined effects of fosamprenavir 700mg BID + ritonavir 100mg BID + standardized dose of methadone, on plasma total and unbound methadone enantiomer pharmacokinetics (PK), opiate pharmacodynamic (PD) measures, and safety. The effect of methadone on plasma amprenavir PK will also be assessed by comparison to historical control data.

Timeline

Start
2005-02
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Fosamprenavir Small molecule 700 mg
Subject Methadone Other / unclassified
Background Ritonavir Other / unclassified 100 mg

Indications

No indication recorded.